KMT2A and acute myeloid leukemia: Gene expression microarray data revealed that 762 and 209 genes were upregulated and downregulated, respectively, more than 2-folds in KMT2A-PTD AML with DNMT3A mutations compared to DNMT3A-WT samples (Supplemental Datasets S1, S2).